Clinical Pharmacodynamic Effects of the Growth Hormone Receptor Antagonist Pegvisomant: Implications for Cancer Therapy
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-06-1910
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2007
Authors
Publisher
American Association for Cancer Research (AACR)